Healthcare of Ontario Pension Plan Trust Fund Raises Stake in IDEX Corporation $IEX

Healthcare of Ontario Pension Plan Trust Fund increased its position in IDEX Corporation (NYSE:IEX) by 1,242.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 39,701 shares of the industrial products company’s stock after buying an additional 36,743 shares during the period. Healthcare of Ontario Pension Plan Trust Fund’s holdings in IDEX were worth $7,525,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of IEX. Primecap Management Co. CA raised its holdings in IDEX by 86.5% in the 4th quarter. Primecap Management Co. CA now owns 3,226,787 shares of the industrial products company’s stock valued at $574,174,000 after acquiring an additional 1,496,207 shares during the last quarter. Dodge & Cox boosted its holdings in shares of IDEX by 266.7% during the fourth quarter. Dodge & Cox now owns 1,262,550 shares of the industrial products company’s stock worth $224,658,000 after purchasing an additional 918,208 shares during the last quarter. Norges Bank purchased a new stake in shares of IDEX in the fourth quarter valued at $162,788,000. Millennium Management LLC grew its position in shares of IDEX by 293.6% in the fourth quarter. Millennium Management LLC now owns 1,063,763 shares of the industrial products company’s stock valued at $189,286,000 after purchasing an additional 793,530 shares during the period. Finally, Balyasny Asset Management L.P. increased its stake in IDEX by 35,817.3% in the fourth quarter. Balyasny Asset Management L.P. now owns 720,142 shares of the industrial products company’s stock valued at $128,142,000 after purchasing an additional 718,137 shares during the last quarter. Hedge funds and other institutional investors own 97.96% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have commented on IEX. Royal Bank Of Canada lifted their price target on IDEX from $252.00 to $261.00 and gave the company an “outperform” rating in a report on Thursday, July 16th. Oppenheimer raised their target price on shares of IDEX from $250.00 to $260.00 and gave the stock an “outperform” rating in a research report on Tuesday, July 21st. Stifel Nicolaus boosted their target price on shares of IDEX from $250.00 to $257.00 and gave the company a “buy” rating in a report on Monday, July 20th. Robert W. Baird set a $257.00 price target on shares of IDEX in a research report on Thursday, April 30th. Finally, Seaport Research Partners reaffirmed a “buy” rating and set a $250.00 price target on shares of IDEX in a research note on Tuesday, May 5th. Six analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, IDEX has an average rating of “Moderate Buy” and a consensus target price of $244.00.

Insider Buying and Selling at IDEX

In related news, CEO Eric D. Ashleman sold 15,385 shares of the firm’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $215.22, for a total transaction of $3,311,159.70. Following the completion of the sale, the chief executive officer directly owned 66,658 shares of the company’s stock, valued at approximately $14,346,134.76. This trade represents a 18.75% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.50% of the company’s stock.

IDEX Price Performance

IEX stock opened at $229.32 on Thursday. The firm has a market cap of $16.97 billion, a P/E ratio of 33.92, a price-to-earnings-growth ratio of 2.21 and a beta of 0.98. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.40 and a current ratio of 3.39. IDEX Corporation has a 1 year low of $157.25 and a 1 year high of $243.80. The stock has a 50-day simple moving average of $220.26 and a 200-day simple moving average of $208.04.

IDEX (NYSE:IEX) last released its quarterly earnings results on Wednesday, July 29th. The industrial products company reported $2.32 EPS for the quarter, topping the consensus estimate of $2.11 by $0.21. The firm had revenue of $920.60 million for the quarter, compared to analyst estimates of $905.38 million. IDEX had a return on equity of 15.29% and a net margin of 14.38%.IDEX’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same period in the previous year, the company posted $2.07 EPS. IDEX has set its FY 2026 guidance at 8.700-8.850 EPS and its Q3 2026 guidance at 2.200-2.250 EPS. On average, equities analysts predict that IDEX Corporation will post 8.48 earnings per share for the current fiscal year.

IDEX Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, July 24th. Stockholders of record on Monday, July 6th were paid a $0.73 dividend. The ex-dividend date was Monday, July 6th. This represents a $2.92 annualized dividend and a dividend yield of 1.3%. IDEX’s dividend payout ratio is 43.20%.

Trending Headlines about IDEX

Here are the key news stories impacting IDEX this week:

• Positive Sentiment: IDEX reported second-quarter adjusted EPS of $2.32, exceeding the $2.11 consensus estimate, while revenue of $920.6 million topped expectations of approximately $905.4 million. Revenue increased 6% year over year, and adjusted EBITDA margin expanded to 28.1%. IDEX Q2 Earnings and Revenues Top Estimates
• Positive Sentiment: Orders rose 28% organically to a record roughly $1.07 billion, pointing to strong demand and better order visibility for upcoming quarters. Management cited continued strength tied to data centers, semiconductors, and space and defense markets. IDEX rises after Q2 earnings beat and guidance hike
• Positive Sentiment: Management raised its fiscal 2026 adjusted EPS guidance to $8.70-$8.85, above the prior $8.35-$8.55 range and the $8.49 analyst consensus. Full-year organic sales growth is now expected at 5%-6%; third-quarter EPS guidance of $2.20-$2.25 also slightly exceeds consensus. IDEX Q2 2026 Earnings Call Highlights
• Neutral Sentiment: IDEX returned capital through approximately $77 million of share repurchases and $54 million in dividends, supporting shareholder returns but leaving less cash for other uses. IDEX Q2 sales rise to record $921 million
• Negative Sentiment: Recent reported insider activity showed two open-market sales by CEO Eric Ashleman totaling 15,385 shares, with no purchases. This is a secondary sentiment concern, although the sales may reflect personal liquidity or scheduled transactions.

IDEX Profile

IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.

Operations at IDEX are organized into three principal segments.